Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Severe Canavan disease (CD) is a rapidly progressing neurodegenerative disorder characterized by leukodystrophy with macrocephaly, severe developmental delay and hypotonia.
Features include very common findings: Macrocephaly, Low muscle tone (hypotonia), Global developmental delay, and Motor delay and others; and common findings: Damage to the optic nerve (optic atrophy), Irritability, Seizure, and Lethargy and others. 34 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 13 | Global developmental delay, Absent speech, Inability to walk |
Biomarker and diagnostic research for severe Canavan disease has been reported in the published literature.
Phenotype severity distribution: 11 very common features, 16 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for severe Canavan disease.
56 publications have been identified in PubMed for severe Canavan disease. Research spans Review / Meta-Analysis (18%), Case Report / Case Series (16%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 10 | 18% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:25 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Digestive system |
5 |
Vomiting, Gastroesophageal reflux, Feeding difficulties |
Muscles | 3 | Low muscle tone (hypotonia), Damage to the optic nerve (optic atrophy), Cerebral white matter atrophy |
Eyes | 2 | Damage to the optic nerve (optic atrophy), Blindness |
Head and neck | 1 | Macrocephaly |
Bones and joints | 1 | Joint stiffness |
9 |
16% |
Disease patterns and progression | 9 | 16% |
Clinical study results | 8 | 15% |
Testing and diagnosis research | 7 | 13% |
Laboratory research | 6 | 11% |
New treatment approaches | 4 | 7% |
Other research | 2 | 4% |
Nayeen MJ (2026). [PMID: 41675922](https://pubmed.ncbi.nlm.nih.gov/41675922/). *ACS Med Chem Lett*. [Gene Therapy / Novel Therapeutics]
Jenkins TO (2026). [PMID: 41593004](https://pubmed.ncbi.nlm.nih.gov/41593004/). *Thorax*. [Epidemiology / Natural History]
Aaron R (2026). [PMID: 42143119](https://pubmed.ncbi.nlm.nih.gov/42143119/). *Sci Rep*. [Epidemiology / Natural History]
Zhan PL (2026). [PMID: 40588180](https://pubmed.ncbi.nlm.nih.gov/40588180/). *Ann Thorac Surg*. [Epidemiology / Natural History]
Jenkins TO (2026). [PMID: 41915553](https://pubmed.ncbi.nlm.nih.gov/41915553/). *Ann Am Thorac Soc*. [Epidemiology / Natural History]
Vanderschoot KA (2026). [PMID: 41856123](https://pubmed.ncbi.nlm.nih.gov/41856123/). *Anal Chem*. [Diagnostic / Biomarker]
Rahim AA (2026). [PMID: 41389437](https://pubmed.ncbi.nlm.nih.gov/41389437/). *Pharmacol Rev*. [Review / Meta-Analysis]
Wyler B (2026). [PMID: 41714923](https://pubmed.ncbi.nlm.nih.gov/41714923/). *Postgrad Med*. [Epidemiology / Natural History]
Townsend EL (2026). [PMID: 41806495](https://pubmed.ncbi.nlm.nih.gov/41806495/). *Pediatr Neurol*. [Epidemiology / Natural History]
Jackson N (2026). [PMID: 41576940](https://pubmed.ncbi.nlm.nih.gov/41576940/). *Stem Cell Reports*. [Basic Science / Preclinical]
AI-curated news mentioning severe Canavan disease
Updated May 16, 2026
A study published in PubMed reveals the prevalence and carrier frequency of Canavan disease in a South Indian community, highlighting its implications for research and public health initiatives. This research underscores the need for targeted awareness and screening programs in affected populations.